Assessing pathological detoxification fear among methadone maintenance patients: the DFSS.
This study assessed the reliability, validity, discriminative accuracy, and factor structure of the Detoxification Fear Survey Schedule (DFSS). Prevalence of detoxification fear and its correlates also were assessed. Random samples from three geographically, culturally, and racially disparate populations (N = 271) of treated opioid addicts were used. The DFSS had a test-retest r = .935 and demonstrated several indicants of validity. A briefer version (DFSS-14) showed superior psychometric properties and could identify correctly 81% of the detox fear subjects while it excluded 55% of nonfear subjects. The DFSS-14 had a replicated three-factor structure that accounted for 62.1% of total item variance in the validation sample. Factor two, probably best named dose reduction fear, was replicated in all populations. A cut-off score set at the nonfear mean is recommended for clinical use. A brief clinical interview of positive scorers quickly should eliminate false positives and, thus, efficiently identify most of those with detoxification fear.
Milby
J B
JB
Psychology Service, Veterans Administration Medical Center, Birmingham, Alabama 35233.
Gurwitch
R H
RH
Hohmann
A A
AA
Wiebe
D J
DJ
Ling
W
W
McLellan
A T
AT
Woody
G E
GE
D000328:Adult; D005239:Fear; D005260:Female; D006801:Humans; D008658:Inactivation, Metabolic; D008297:Male; D008691:Methadone / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000523:psychology / Q000534:rehabilitation*; D011594:Psychometrics; D013375:Substance Withdrawal Syndrome / Q000523:psychology*
D008691:Methadone